FibroGen's lung disease treatment fails in late-stage trial

Kyntra Bio

26/06/2023 12:11

June 26 (Reuters) - FibroGen  FGEN.O  said on Monday its
experimental drug, pamrevlumab, for treating lung disease
idiopathic pulmonary fibrosis did not meet its main goal in a
late-stage study. 

 (Reporting by Raghav Mahobe in Bengaluru; Editing by Shinjini
Ganguli)
 ((Raghav.Mahobe@thomsonreuters.com;))